SCHEMBL10751306

SCHEMBL10751306

Cn1nc(CO)nc1NCCCCOc1cccc(CN2CCCCC2)c1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.52
TP53 P04637 1/20 0.52
CYP1A2 P05177 1/20 0.52
CYP3A4 P08684 1/20 0.52
CYP2D6 P10635 1/20 0.52
TSHR P16473 1/20 0.52
MAPK1 P28482 1/20 0.52
THPO P40225 1/20 0.52
MTOR P42345 1/20 0.52
RAB9A P51151 1/20 0.52
HIF1A Q16665 1/20 0.52
HRH2 P25021 6/20 0.51
HRH3 Q9Y5N1 1/20 0.49
MEN1 O00255 1/20 0.48
GMNN O75496 1/20 0.48
ALDH1A1 P00352 1/20 0.48
LMNA P02545 1/20 0.48
MAPT P10636 1/20 0.48
PMP22 Q01453 1/20 0.48
KMT2A Q03164 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Lavoltidine SCHEMBL1142 0.97 SMN1; SMN2 (0.55) SMN1; SMN2TP53CYP1A2CYP3A4CYP2D6
SCHEMBL11010882 0.97 SMN1; SMN2 (0.55) SMN1; SMN2TP53CYP1A2CYP3A4CYP2D6
Lavoltidine SCHEMBL30095469 0.97 SMN1; SMN2 (0.55) SMN1; SMN2TP53CYP1A2CYP3A4CYP2D6
SCHEMBL11106320 0.97 SMN1; SMN2 (0.55) SMN1; SMN2TP53CYP1A2CYP3A4CYP2D6
Acetic Acid SCHEMBL11011722 0.96 HRH2 (0.52) SMN1; SMN2TP53CYP1A2CYP3A4CYP2D6
Lavoltidine SCHEMBL633369 0.91 SMN1; SMN2 (0.52) SMN1; SMN2TP53CYP1A2CYP3A4CYP2D6
SCHEMBL11100251 0.91 TP53 (0.47) SMN1; SMN2TP53CYP1A2CYP3A4CYP2D6
SCHEMBL11014531 0.91 HRH2 (0.53) SMN1; SMN2TP53CYP1A2CYP3A4CYP2D6
SCHEMBL10750320 0.91 TP53 (0.52) SMN1; SMN2TP53CYP1A2CYP3A4CYP2D6
SCHEMBL4607091 0.90 SMN1; SMN2 (0.54) SMN1; SMN2TP53CYP1A2CYP3A4CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0016565-B1 1,2,4-TRIAZOLE DERIVATIVES, PROCESSES FOR THEIR PRODUCTION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM GLAXO GROUP LIMITED (GB) 1984-05-23 EP claimed
EP-0016565-A1 1,2,4-Triazole derivatives, processes for their production and pharmaceutical compositions containing them GLAXO GROUP LIMITED (GB) 1980-10-01 EP claimed
US-4670448-A ANTIINFLAMMATORY AGENTS, HISTAMINE H2-ANTAGONISTS GLAXO GROUP LIMITED (GB) 1987-06-02 US disclosed
US-4536508-A ANTIALLERGENS AND ANTIINFLAMMATORY AGENTS GLAXO GROUP LIMITED (GB) 1985-08-20 US disclosed
EP-0016565-B1 1,2,4-TRIAZOLE DERIVATIVES, PROCESSES FOR THEIR PRODUCTION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM GLAXO GROUP LIMITED (GB) 1984-05-23 EP disclosed
EP-0016565-A1 1,2,4-Triazole derivatives, processes for their production and pharmaceutical compositions containing them GLAXO GROUP LIMITED (GB) 1980-10-01 EP disclosed